Custom Solutions for your

Drug Discovery Needs

0 Days

Turn Around Time(TAT) ADME Tier 1 Screening assay results

0 Days

Turn Around Time(TAT) Invivo Pharmacokinetic Results

0 %

Time savings in data preparation and Report Generation

0 Days

Turn Around Time(TAT) ADME Tier 1 Screening assay results

0 Days

Turn Around Time(TAT) Invivo Pharmacokinetic Results

0 %

Time savings in data preparation and Report Generation

Our Services

DMPK

PharmaJen’s DMPK expertise accelerates drug discovery success. Our flexible, tailored solutions cover physicochemical properties, in vitro ADME, drug-transporter studies, and in vivo pharmacokinetics across multiple species, ensuring comprehensive support throughout your drug discovery journey.

Chemistry

We excel in advancing your drug discovery chemistry programs. Our specialized expertise covers custom synthesis, multistep organic synthesis, and process optimization. Our services extend to heterocyclic and asymmetric synthesis, macrocycles, and organometallic chemistry.

Bioanalysis

PharmaJen’s advanced Bioanalysis service, combining cutting-edge technology with extensive expertise. We offer precise metabolite quantification for pharmacokinetics, toxicokinetics, bioequivalence, and exposure-response studies. Our UPLC-MS/MS capabilities ensure rapid, accurate, and sensitive quantification from diverse biological matrices.

Preclinical Toxicology

Pharmajen’s robust and validated safety and toxicity test systems enable the accurate assessment of molecule’s safety and toxicity profile at the early stage of drug discovery. We offer a range of exploratory and non-GLP toxicology services according to the regulatory guidelines that facilitate rapid decision making for drug candidate selection.

IND Enabling Studies

PharmaJen specializes in Investigational New Drug (IND) enabling studies, meticulously aligned with regulatory expectations. Our comprehensive in vitro investigations encompass a range of crucial assessments for successful IND programs. PharmaJen ensures that your drug candidates meet regulatory requirements and advance confidently in the drug development process.

Latest Blogs

Explore our blog for the latest in drug discovery research, insightful perspectives on industry topics, and our take on the latest advancements in the field.

UGT1A1 and UGT1A3: Decoding the Mysteries of Human Microsomal Enzymes

Enzymes act as crucial signposts in the intricate maze of human metabolism, guiding and accelerating various biochemical reactions. Among these, the UGT1A1 and UGT1A3 enzymes
Read More →

Harnessing Advanced Predictive Models to Propel Drug Metabolism and Pharmacokinetics

The quest for ensuring drug efficacy and safety is perennial in the complex realm of Drug Metabolism and Pharmacokinetics (DMPK). The pathway from drug discovery
Read More →

The Role of Drug Metabolism and Pharmacokinetics (DMPK) in Understanding and Combating Antimicrobial Resistance

Drug metabolism is a complex process involving converting drugs into more....
Read More →

Recent Advances in Drug Metabolism and Pharmacokinetics: Innovation at PharmaJen

At PharmaJen, we are committed to staying at the forefront of Drug Metabolism and Pharmacokinetics (DMPK) research. We aim to drive advancements that revolutionize drug
Read More →

The Role of Generative AI in Predicting Drug Metabolism and Pharmacokinetics

Drug discovery has traditionally been a costly and complex process fraught with significant challenges. An essential part of this process is understanding drug metabolism and
Read More →

Delving into Ivermectin’s Influence on Bile Acids: A Scientific Exploration

PharmaJen recently published an article titled "Simultaneous determination of seven bile acids to study the effect of ivermectin on their plasma levels in rats by
Read More →

LinkedIn Posts

Get In Touch

Send us a message

Scroll to Top